[
  {
    "ts": null,
    "headline": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "summary": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
    "url": "https://finnhub.io/api/news?id=f72b875e93932c51a2c7ca0e0e1eb3bc0cc300e551c610c911733d832ca53d59",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760459820,
      "headline": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "id": 137110226,
      "image": "",
      "related": "BSX",
      "source": "MarketWatch",
      "summary": "Boston Scientific Corp. stock underperforms Tuesday when compared to competitors despite daily gains",
      "url": "https://finnhub.io/api/news?id=f72b875e93932c51a2c7ca0e0e1eb3bc0cc300e551c610c911733d832ca53d59"
    }
  },
  {
    "ts": null,
    "headline": "Edwards Lifesciences: Inflection Incoming, But When?",
    "summary": "Get insights on Edwards Lifesciences Corporation: market leadership, growth trends, and valuation analysis. Click for more on EW stock prospects.",
    "url": "https://finnhub.io/api/news?id=cb8977ca318ea146378c508e6e0722ac9d5b4bd7ebd7f13c52dcb9af337b0341",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760452589,
      "headline": "Edwards Lifesciences: Inflection Incoming, But When?",
      "id": 137082920,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/2232288705/image_2232288705.jpg?io=getty-c-w1536",
      "related": "BSX",
      "source": "SeekingAlpha",
      "summary": "Get insights on Edwards Lifesciences Corporation: market leadership, growth trends, and valuation analysis. Click for more on EW stock prospects.",
      "url": "https://finnhub.io/api/news?id=cb8977ca318ea146378c508e6e0722ac9d5b4bd7ebd7f13c52dcb9af337b0341"
    }
  },
  {
    "ts": null,
    "headline": "What Makes Boston Scientific Corporation (BSX) an Investment Choice?",
    "summary": "Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market continued its strong performance in the third quarter of 2025, driven by enthusiasm for generative AI and strength in the semiconductor sector. In the quarter, the focus […]",
    "url": "https://finnhub.io/api/news?id=1749165fcb75ca9dbfbef0df6d2c3e0ac2bc312065fe1d068cfe5077f732ad7b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760446788,
      "headline": "What Makes Boston Scientific Corporation (BSX) an Investment Choice?",
      "id": 137085938,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market continued its strong performance in the third quarter of 2025, driven by enthusiasm for generative AI and strength in the semiconductor sector. In the quarter, the focus […]",
      "url": "https://finnhub.io/api/news?id=1749165fcb75ca9dbfbef0df6d2c3e0ac2bc312065fe1d068cfe5077f732ad7b"
    }
  },
  {
    "ts": null,
    "headline": "Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025?",
    "summary": "If you are like many investors trying to decide whether Boston Scientific belongs in your portfolio right now, you are not alone. There is plenty of buzz swirling around medtech stocks this year, but Boston Scientific deserves special attention. Despite market jitters and shifting risk appetites, the company’s share price, which last closed at $94.95, has shown resilience and impressive long-term growth. Although in the past week it is down 1.8%, and over the past month it is off by 7.6%, a...",
    "url": "https://finnhub.io/api/news?id=5dbe129a6217c39bc29575cb931ee628b79dd3c11b03cb3ff9885869d29a8cc1",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760443638,
      "headline": "Is Boston Scientific’s Share Price Justified After Its Recent 7.6% Monthly Drop in 2025?",
      "id": 137085939,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "If you are like many investors trying to decide whether Boston Scientific belongs in your portfolio right now, you are not alone. There is plenty of buzz swirling around medtech stocks this year, but Boston Scientific deserves special attention. Despite market jitters and shifting risk appetites, the company’s share price, which last closed at $94.95, has shown resilience and impressive long-term growth. Although in the past week it is down 1.8%, and over the past month it is off by 7.6%, a...",
      "url": "https://finnhub.io/api/news?id=5dbe129a6217c39bc29575cb931ee628b79dd3c11b03cb3ff9885869d29a8cc1"
    }
  },
  {
    "ts": null,
    "headline": "1 Profitable Stock with Promising Prospects and 2 We Find Risky",
    "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
    "url": "https://finnhub.io/api/news?id=58ca8862bf7c8fe5f80beb91b4bd01d91d4bfd1d061844c636f383f411248d67",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1760417002,
      "headline": "1 Profitable Stock with Promising Prospects and 2 We Find Risky",
      "id": 137085941,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "Not all profitable companies are built to last - some rely on outdated models or unsustainable advantages. Just because a business is in the green today doesn’t mean it will thrive tomorrow.",
      "url": "https://finnhub.io/api/news?id=58ca8862bf7c8fe5f80beb91b4bd01d91d4bfd1d061844c636f383f411248d67"
    }
  }
]